|
DNAJC16 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.44829999607177E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.74040000189279E-08 |
| Normal-vs-Stage2 |
2.73219999957774E-07 |
| Normal-vs-Stage3 |
1.33130000357085E-08 |
| Normal-vs-Stage4 |
3.92050003572564E-09 |
| Stage1-vs-Stage2 |
8.517000E-01 |
| Stage1-vs-Stage3 |
6.688800E-01 |
| Stage1-vs-Stage4 |
1.860440E-01 |
| Stage2-vs-Stage3 |
6.189800E-01 |
| Stage2-vs-Stage4 |
3.236200E-01 |
| Stage3-vs-Stage4 |
5.365200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.3678000005134E-08 |
| Normal-vs-AfricanAmerican |
2.14199999959419E-08 |
| Normal-vs-Asian |
1.719960E-03 |
| Caucasian-vs-AfricanAmerican |
9.297800E-01 |
| Caucasian-vs-Asian |
5.475000E-01 |
| AfricanAmerican-vs-Asian |
5.818800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.81349999461844E-08 |
| Normal-vs-Female |
8.47550000182551E-08 |
| Male-vs-Female |
2.888600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.61390000147566E-08 |
| Normal-vs-Extreme_Weight |
2.97790003767062E-09 |
| Normal-vs-Obese |
4.98979999541405E-08 |
| Normal-vs-Extreme_Obese |
2.352700E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.707040E-01 |
| Normal_Weight-vs-Obese |
8.417000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.971600E-01 |
| Extreme_Weight-vs-Obese |
8.251700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.106600E-01 |
| Obese-vs-Extreme_Obese |
9.045600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.22749999556626E-08 |
| Normal-vs-Age(41-60Yrs) |
4.2523000010064E-08 |
| Normal-vs-Age(61-80Yrs) |
1.42160000438096E-08 |
| Normal-vs-Age(81-100Yrs) |
4.18440000427012E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.258000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.793800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.621400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.074400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.617000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.409200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.6290000015573E-08 |
| Normal-VS-Type2 PRCC |
4.53159954005855E-10 |
| Normal-VS-KIRP CIMP |
3.95140000053473E-07 |
| Normal-VS-Unclassified PRCC |
6.51470000168075E-08 |
| Type1 PRCC-VS-Type2 PRCC |
3.371800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.907800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.184600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.371000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.156600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.384600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.25589999511178E-08 |
| Normal-vs-N1 |
1.52369999950608E-08 |
| Normal-vs-N2 |
5.077400E-03 |
| N0-vs-N1 |
9.061600E-01 |
| N0-vs-N2 |
3.948800E-01 |
| N1-vs-N2 |
3.890000E-01 |
|
|
